Lisa Walter
Stock Analyst at RBC Capital
(1.02)
# 3,890
Out of 5,032 analysts
91
Total ratings
42.3%
Success rate
-1.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Reiterated: Buy | $677 | $536.40 | +26.21% | 14 | Sep 30, 2026 | |
| VRDN Viridian Therapeutics | Reiterated: Buy | $36 → $38 | $19.00 | +100.00% | 8 | Sep 22, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $155 | $92.45 | +67.66% | 8 | Sep 14, 2026 | |
| EYPT EyePoint | Downgraded: Hold | $37 → $5 | $3.15 | +58.73% | 10 | Aug 17, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $35 | $12.92 | +170.90% | 25 | Aug 14, 2026 | |
| KRYS Krystal Biotech | Initiated Coverage: Buy | $400 | $334.85 | +19.46% | 1 | Aug 14, 2026 | |
| MGTX MeiraGTx Holdings | Reiterated: Buy | $26 → $27 | $10.92 | +147.25% | 9 | Aug 13, 2026 | |
| IRD Opus Genetics | Reiterated: Buy | $10 → $9 | $4.38 | +105.48% | 2 | Aug 6, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterated: Buy | $148 → $135 | $81.43 | +65.79% | 3 | Aug 6, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $30 | $7.25 | +313.79% | 11 | Aug 3, 2026 |
United Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: $677
Current: $536.40
Upside: +26.21%
Viridian Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $36 → $38
Current: $19.00
Upside: +100.00%
Rhythm Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: $155
Current: $92.45
Upside: +67.66%
EyePoint
Aug 17, 2026
Downgraded: Hold
Price Target: $37 → $5
Current: $3.15
Upside: +58.73%
4D Molecular Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $35
Current: $12.92
Upside: +170.90%
Krystal Biotech
Aug 14, 2026
Initiated Coverage: Buy
Price Target: $400
Current: $334.85
Upside: +19.46%
MeiraGTx Holdings
Aug 13, 2026
Reiterated: Buy
Price Target: $26 → $27
Current: $10.92
Upside: +147.25%
Opus Genetics
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $9
Current: $4.38
Upside: +105.48%
Mirum Pharmaceuticals
Aug 6, 2026
Reiterated: Buy
Price Target: $148 → $135
Current: $81.43
Upside: +65.79%
Ocular Therapeutix
Aug 3, 2026
Reiterated: Buy
Price Target: $30
Current: $7.25
Upside: +313.79%